the in vitro activity of the new parenteral cephalosporin bmy-28142 was compared with that of cephalothin , cefoxitin , cefotaxime , ceftriaxone , moxalactam , aztreonam and ceftazidime , against a total of 374 recent multiresistant gram-negative microorganisms of nosocomial origin .
C3536856
cephalosporin
C0007561
ceftriaxone